3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
21
Carcinoma, Renal Cell
10
Neuroendocrine Tumors
7
Neoplasm Metastasis
7
Recurrence
4
Endometrial Neoplasms
4
Tuberous Sclerosis
3
Triple Negative Breast Neoplasms
3
Neoplasms
3
Kidney Neoplasms
3
von Hippel-Lindau Disease
2
Skin Neoplasms
2
Sarcoma
2
Meningioma
2
Glioma
2
Gastro-enteropancreatic neuroendocrine tumor
2
Diffuse Intrinsic Pontine Glioma
2
Carcinoma, Hepatocellular
2
Adenoma, Islet Cell
2
Waldenstrom Macroglobulinemia
1
Vascular Malformations
1
Unilateral Breast Neoplasms
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thymus Neoplasms
1
Seizures
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Phase IB
1
Interventions
Cyclophosphamide
6
Vincristine
3
Temozolomide
3
Radiotherapy
3
Cisplatin
3
Automobiles
3
fludarabine
2
Etoposide
2
Eflornithine
2
Carboplatin
2
omburtamab I-131
1
ibrutinib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
belzutifan
1
Zoledronic Acid
1
Thiotepa
1
Tamoxifen
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Pemetrexed
1
ONC206
1
Nivolumab
1
Mesna
1
Maintenance Chemotherapy
1
Lomustine
1
Isotretinoin
1
Induction Chemotherapy
1
Hydrocortisone
1
HhAntag691
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Everolimus
×
1 year
×
Clear all
No trials found.